Some Japanese people with high cholesterol don't respond as well to certain cholesterol drugs if they have a specific gene variant — their cholesterol doesn't drop as much as in people without that gene.

What we've found so far is that people with a specific gene variant may not respond as strongly to certain cholesterol-lowering drugs. Our analysis of the available research suggests this could be linked to genetics, at least in some populations. We reviewed evidence showing that some Japanese individuals with high cholesterol who have a particular gene variant do not see as much of a drop in their cholesterol levels when taking certain medications, compared to those without the variant [1]. This observation is based on findings where 42.0 studies or assertions support this idea, and none refute it [1]. While the number of supporting assertions is high, we note that only one unique claim was analyzed, so our current view is limited in scope. The gene variant mentioned may affect how the body processes these drugs, possibly influencing their effectiveness. However, we don’t have enough information from the evidence to say how this applies to other ethnic groups or to determine the exact size of the effect. We also don’t know which specific drugs are involved or how this variant compares to others that might influence drug response. Our current analysis shows the evidence leans toward a link between this genetic trait and a weaker response to certain cholesterol medications in some people. But because the data we’ve reviewed so far focuses on a specific population and is based on a single assertion, we can’t generalize these findings broadly. Practical takeaway: If you have high cholesterol and a family background where medications don’t seem to work as expected, your genes might play a role — but more research is needed to know exactly how and for whom this matters.